Anticancer oral drugs are medications designed to fight cancer by inhibiting tumor growth. Key compounds include alkylating agents (e.g., cyclophosphamide), antimetabolites (e.g., methotrexate), and targeted therapies (e.g., imatinib). Used in oncology, they require specialized machinery for formulation. Packaged in blister packs, they improve patient compliance and cancer treatment outcomes.